Offstream
news

---

Changes

1. Ukraine grants the approval of CoronaVac vaccine developed by Sinovac.
   2021-03-10 01:05:27 (First version)
2. Ukraine grants approval for the Sinovac CoronaVac vaccine.
   (Current version)

---

Related

Indonesia begins administering the COVID-19 vaccine for children between the ages of 6 and 11 years, with 100 children receiving the Sinovac Coronavac vaccine.
2021-12-14

Hong Kong authorises the usage of the Sinovac CoronaVac vaccine for children between the ages of 3 and 17 years.
2021-11-20

Venezuela receives their first shipment of 693,600 doses of the Sinovac Coronavac vaccine supplied through the COVAX initiative.
2021-09-7

The Public Health Institute of Chile approves the usage of the Sinovac CoronaVac vaccine for children over the age of six.
2021-09-6

Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
2021-08-12

The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.
2021-08-11

The World Health Organization issues an emergency use authorization for Sinovac's CoronaVac vaccine, becoming the second Chinese-made vaccine to be approved on an emergency basis after BBIBP-CorV and thereby making it eligible for use as part of the COVAX initiative.
2021-06-1

The Drug Regulatory Authority grants Emergency Use Authorization for Sinovac CoronaVac vaccine.
2021-04-9

The Philippines begins its vaccination campaign against COVID-19 using the Sinovac CoronaVac vaccine donated by China, with the first doses administered to healthcare workers in Metro Manila.
2021-03-1

Indonesia aims to start administering COVID-19 vaccines early next month, according to the Coordinating Ministry for Maritime and Investment Affairs. Sinopharm and G42 Healthcare will supply five million doses starting next month, CanSino Biologics will supply 100,000 doses that same time, and Sinovac will supply three million doses of CoronaVac by December. All three vaccines are currently in Phase III trials in various countries.
2020-10-12